CsWRKY24 gene and its application in regulating caffeine synthesis in tea leaves

By cloning and validating the CsWRKY24 gene as a negative regulator, the expression of the CsTCS1 gene in tea trees was suppressed, solving the problem of lack of negative regulation in tea quality improvement and molecular breeding, and realizing the breeding of low-caffeine tea varieties and the improvement of tea quality.

CN123108016APending Publication Date: 2026-11-17ANHUI AGRICULTURAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611614862.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-10-19
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

The lack of transcription factors that negatively regulate caffeine synthesis in existing technologies hinders the improvement of tea quality and the process of molecular breeding, limiting the overall understanding of the formation mechanism of tea flavor and quality.

Method used

The CsWRKY24 gene in tea plants was cloned and verified as a negative regulator of caffeine synthesis. By constructing a recombinant expression vector and genetically engineered bacteria, the expression of the CsTCS1 gene was inhibited, thereby reducing the accumulation of caffeine in tea leaves.

Benefits of technology

The molecular regulatory network of caffeine biosynthesis in tea trees has been improved, enabling the breeding of low-caffeine tea varieties and enhancing the genetic resources and technical support for tea quality improvement.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123108016A_ABST
    Figure CN123108016A_ABST
Patent Text Reader

Abstract

This invention belongs to the field of genetic engineering technology and discloses a CsWRKY24 gene and its application in regulating caffeine synthesis in tea. The nucleotide sequence of the CsWRKY24 gene is shown in SEQ ID NO. 1, and the amino acid sequence of the encoded protein is shown in SEQ ID NO. 2. This gene is a negative regulatory transcription factor for caffeine synthesis, which can bind to the promoter of the caffeine synthase gene CsTCS1 and inhibit CsTCS1 transcription. Transient overexpression of this gene in tea leaves significantly reduces caffeine content; inhibition of endogenous CsWRKY24 expression using antisense oligonucleotides significantly increases CsTCS1 expression and caffeine content. This invention improves the transcriptional regulatory network for caffeine synthesis in tea trees, providing genetic resources and technical support for molecular breeding of low-caffeine tea trees.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of genetic engineering technology, specifically to the CsWRKY24 gene and its application in regulating the synthesis of caffeine in tea. Background Technology

[0002] Caffeine, the most consumed purine alkaloid globally, is widely used in beverage processing and the research and development of neurological drugs. At least 100 plants are known to synthesize caffeine, with tea leaves being a particularly prominent source (approximately 2%–5% of dry weight). Coffee (1%–2%) and cocoa (approximately 0.03%) are also major sources. It can be said that the presence of caffeine has established the core position of tea, coffee, and cocoa as the three major non-alcoholic beverages in modern soft drink culture.

[0003] Caffeine was initially thought to be an allelochemical secreted by plants, capable of entering the soil and interfering with the germination of neighboring plant seeds. However, in a broader ecological context, caffeine forms a multi-layered chemical defense barrier for plants. In tea plants, caffeine synthesis is strongly induced by anthracnose infection, and its antibacterial activity is even stronger than that of polyphenols. Population-level surveys further show that the caffeine content in the new shoots of insect-resistant tea varieties is significantly higher than that of susceptible varieties, and there is a significant negative correlation between insect population density and caffeine content. Furthermore, heterologous synthesis of caffeine in transgenic tobacco and chrysanthemum also significantly enhances the plant's insect resistance and antibacterial ability. Therefore, caffeine, as a broad-spectrum natural insect-resistant and antibacterial substance, comprehensively participates in the defense of tea plants against biological stress and has broad prospects in green tea production.

[0004] Caffeine's influence on the flavor and quality of tea is equally undeniable. While inherently bitter, it forms complex complexes with a fresh, savory flavor when combined with polyphenols like theaflavins via hydrogen bonds. This characteristic has become a key indicator of black tea quality. Regarding health benefits, animal models and epidemiological surveys have confirmed that moderate caffeine intake has significant protective effects on the body, including protecting the nervous system, accelerating metabolism, enhancing cognitive response and memory, promoting cardiovascular contraction, assisting in fat degradation, and acting as an antioxidant. However, long-term excessive intake can lead to dependence, irritability, sleep disorders, and a range of physiological and psychological problems. For children, pregnant women, and the elderly with neurasthenia, caffeine may also cause impaired neurodevelopment, gastrointestinal discomfort, and increased cardiac burden. Therefore, breeding low- or caffeine-free tea varieties has become an important direction for breeding research and market expansion, which is of practical significance for expanding the tea-consuming population and alleviating domestic tea overcapacity.

[0005] The core pathway of caffeine biosynthesis in plants is well understood: starting with xanthine nucleotides, it proceeds sequentially through intermediates such as 7-methylxanthine nucleotides, 7-methylxanthine, and theobromine, followed by three-step methylation and one-step nucleotide hydrolysis to finally produce caffeine. Tea caffeine synthase 1 (CsTCS1) is expressed most highly in young leaves and is responsible for catalyzing the final 1-N methylation reaction from theobromine to caffeine, making it the rate-limiting enzyme in this pathway. Caffeine synthesis is also finely regulated at the transcriptional level—for example, CsNAC07 can directly bind to the promoter region of the yhNMT gene, positively promoting caffeine synthesis, while CsMYB184 binds to the CsTCS1 promoter and activates its expression. Currently, transcription factors that negatively regulate caffeine synthesis have not been discovered in tea and other caffeine-rich plants. This gap limits our overall understanding of the mechanisms underlying tea flavor and quality formation and hinders the molecular breeding process for personalized tea varieties with low caffeine content. Further exploration of the regulatory network of caffeine synthesis will provide richer and more usable genetic resources for genetic engineering breeding. Summary of the Invention

[0006] The purpose of this invention is to provide the CsWRKY24 gene and its application in regulating caffeine synthesis in tea, thereby improving the molecular regulatory network of caffeine synthesis in tea plants and providing gene resources and technical means for tea quality improvement and molecular breeding.

[0007] To achieve the above objectives, the present invention provides the following technical solution:

[0008] The present invention provides a CsWRKY24 gene, the nucleotide sequence of which is shown in SEQ ID NO.1 of the sequence listing.

[0009] Preferably, the amino acid sequence encoded by the CsWRKY24 gene is shown in SEQ ID NO.2 of the sequence listing.

[0010] The present invention provides a recombinant expression vector comprising the nucleotide sequence of the CsWRKY24 gene as shown in SEQ ID NO.1.

[0011] Preferably, the recombinant expression vector is pMD. TM 19-T-CsWRKY24 was obtained by ligating the gene fragment shown in SEQ ID NO.1 of the sequence listing into the pMD™19-T Simple Vector vector via enzyme digestion.

[0012] The present invention provides a genetically engineered bacterium containing the recombinant expression vector described above; the genetically engineered bacterium is Escherichia coli DH5α strain or Agrobacterium GV3101 strain.

[0013] This invention provides the application of the CsWRKY24 gene in regulating caffeine synthesis in tea leaves. The nucleotide sequence of the CsWRKY24 gene is shown in SEQ ID NO.1. CsWRKY24 is a negative regulator of caffeine synthesis. By binding to the promoter of the caffeine synthase gene CsTCS1, it inhibits the expression of the CsTCS1 gene, thereby reducing the accumulation of caffeine in tea leaves.

[0014] Preferably, it is used to cultivate low-caffeine tea tree varieties.

[0015] The present invention provides a method for regulating caffeine synthesis in tea leaves, comprising the following steps: (1) cloning the CsWRKY24 gene of tea plant, wherein the nucleotide sequence of the CsWRKY24 gene is shown in SEQ ID NO.1 of the sequence listing; (2) constructing the recombinant expression vector pMD TM 19-T-CsWRKY24; (3) The recombinant expression vector was introduced into tea leaves to achieve overexpression of the CsWRKY24 gene in tea leaves and inhibit caffeine synthesis.

[0016] The present invention provides a method for regulating the synthesis of caffeine in tea leaves, the specific steps of which are as follows: inhibiting the expression of the endogenous CsWRKY24 gene in tea trees by using antisense oligonucleotide technology, relieving the inhibitory effect of the CsWRKY24 gene on the CsTCS1 gene, and increasing the caffeine content in tea leaves.

[0017] Preferably, the antisense oligonucleotide has the following sequence:

[0018] 5'-AAGGGTAGTCTTCGGCGAGGAGGT-3'.

[0019] The beneficial effects of this invention are as follows:

[0020] This invention marks the first cloning of CsWRKY24, a key transcription factor negatively regulating caffeine synthesis in tea plants, and its functional verification was completed in vivo and in vitro. The CsWRKY24 protein can directly bind to the promoter of the rate-limiting enzyme gene CsTCS1, inhibiting CsTCS1 transcription and thus reducing caffeine accumulation in tea leaves. Overexpression of the CsWRKY24 gene can reduce the caffeine content in tea leaves. Inhibiting the expression of endogenous CsWRKY24 gene can relieve its inhibition of CsTCS1, increasing the caffeine content in tea leaves. This invention also provides recombinant expression vectors containing this gene, genetically engineered bacteria, and other biological materials. This invention improves the transcriptional regulatory network of caffeine biosynthesis in tea plants, elucidates the molecular genetic mechanism of bitter substance accumulation in tea, and provides important gene resources and technical support for targeted molecular breeding of new low-caffeine tea varieties. Attached Figure Description

[0021] Figure 1 This is a multiple sequence alignment diagram of CsWRKY24 protein with other plant WRKY repressor proteins in an embodiment of the present invention;

[0022] Figure 2 This is a bar chart illustrating the expression pattern of the CsWRKY24 gene in different tissues of tea plants according to an embodiment of the present invention.

[0023] Figure 3 The figure shows the results of gene expression and caffeine content detection in tea leaves after transient overexpression of CsWRKY24 in an embodiment of the present invention; where A is the gene expression level of CsWRKY24; B is the gene expression level of CsTCS1; C is the caffeine content in the leaves; EV is the empty vector control group, and OE-CsWRKY24 is the overexpression treatment group;

[0024] Figure 4 The figure shows the results of gene expression and caffeine content detection after antisense oligonucleotide inhibition of the endogenous CsWRKY24 gene in an embodiment of the present invention; where A is the expression level of CsWRKY24 gene; B is the expression level of CsTCS1 gene; C is the caffeine content in leaves; SenseODN is the control group, and CsWRKY24-KD is the antisense inhibition treatment group;

[0025] Figure 5 The diagram shows the results of the interaction verification between the CsWRKY24 and CsTCS1 promoters in this embodiment of the invention; where A is the result of the yeast one-hybrid experiment; B is a schematic diagram of the construction of the dual-luciferase vector; C is a fluorescence imaging image of tobacco leaves; and D is a bar chart of the relative activity detection of the CsTCS1 promoter. Detailed Implementation

[0026] Unless otherwise stated, the terms used in this invention generally have the meanings commonly understood by those skilled in the art.

[0027] The present invention will be described in further detail below with reference to specific preparation and application examples and data. It should be understood that these examples are merely illustrative of the invention and are not intended to limit the scope of the invention in any way.

[0028] In the following embodiments, various processes and methods not described in detail are conventional methods known in the art. All primers used are indicated upon their first appearance, and subsequent use of the same primer will use the same indication as the initial indication.

[0029] Example 1:

[0030] Cloning and sequence structure analysis of the CsWRKY24 gene:

[0031] Total ribonucleic acid was extracted from the experimental samples (young leaves of early-maturing tea tree) using the RNAprepPure polysaccharide and polyphenol plant total RNA extraction kit (TIANGEN, catalog number DP441). The obtained total RNA was used as a template to complete the reverse transcription reaction and synthesize complementary deoxyribonucleic acid (cDNA).

[0032] Shucha Zao is a nationally approved superior tea variety, planted in the Anhui Agricultural University Agricultural Industrial Park in Luyang District, Hefei City, Anhui Province.

[0033] Using the prepared cDNA as an amplification template, polymerase chain reaction (PCR) amplification was carried out using specific upstream and downstream primers targeting the CsWRKY24 gene; the forward primer nucleotide sequence was 5'-ATGGCTTCTTCTTCAGAAAT-3', and the reverse primer nucleotide sequence was 5'-TCATCGTAGGTACGAGTCGA-3'.

[0034] The total volume of the PCR amplification system in this experiment was set to 50 μL. The amounts of each component added were as follows: 25 μL of 2×PrimeSTAR MaxPremix premixed enzyme solution, 2 μL each of upstream and downstream specific primers, 2 μL of cDNA template, and sterile double-distilled water (ddH2O) was added to bring the system to 50 μL, corresponding to a sterile double-distilled water volume of 19 μL. The PCR thermal cycling program parameters were set as follows: pre-denaturation at 98℃ for 5 min; followed by 35 amplification cycles, each cycle consisting of denaturation at 98℃ for 10 s, annealing at 56℃ for 15 s, and extension at 72℃ (the extension time was matched to the target fragment length according to the standard of 5 s / kb); after all cycles, a final extension at 72℃ for 10 min was performed.

[0035] The PCR product, after being separated, purified, and recovered by agarose gel electrophoresis, was combined with Takara Bio's pMD... TM The recombinant plasmid pMD was constructed by ligation reaction using the 19-TSimple (Takara, Japan) vector. TM 19-T-CsWRKY24; This plasmid was transformed into E. coli DH5α competent cells, and positive clones were selected and sent to Shanghai Sangon Biotech Co., Ltd. for sequencing. The nucleotide sequence of the CsWRKY24 gene is shown in SEQ ID NO.1 of the sequence listing, as follows:

[0036]

[0037] The amino acid sequence encoded by the CsWRKY24 gene is shown in SEQ ID NO.2 of the sequence listing, as follows:

[0038] MASSSEITTPSNFSFPNPFMSFSDLLAEDYPSTTTTAAAVSRGLSDRITERTGSGVPKFKSIPPPSLPLSPPPVSPSSYFAIPAGLSPAELLDSPVLLSSSNILPSPTTGSFPIQRFNWKSNSNNHNQDIKQERKNYSD FSFHTRTRPPTTSSTTTTFHSQVVPTRVWSNLNWVPCSRPTHPRIPQFRPILKATTMGFNQIIISYNQSSSIREQRRSEDGYNWRKYGQKQVKGSENPRSYYKCTFSNCPTKKKVERSIDGQITEIVYKGNNHNHPKPQNTR RSSSSASSQPIQHSNENPDQSFASNGQIDSVATPENSSISIGDDDFEQTSQKTKSGGDEFDDDEPDAKRWKIEGESAGMSGAGNRTVREPRVVVQTTSDIDILDDGYRWRKYGQKVVKGNPNPRSYYKCTSQGCPVRKHV ERASQDLRSVITTYEGKHNHDVPAPRGSGGGNSIHSVNRPLANSTTNNNAAMAIRPSAMPHQSTTTTTTIMTNPIRNSRLQTSEGQTPFTLEMLQSPGSFGFSGFGSSNYMNQSQHTDNYMFSRTKEEPRDDTFIDSYLR

[0039] Protein domain analysis was performed on the homologous gene protein sequences of CsWRKY24 and other species with known functions in the SMART database, and multiple sequence alignment was performed using ESPript software.

[0040] Figure 1 This is a multiple sequence alignment diagram of the CsWRKY24 protein and other plant WRKY repressor proteins in an embodiment of the present invention. Figure 1 As shown, protein sequence alignment with known WRKY structures in other plants indicates that tea plant CsWRKY24 also possesses a typical WRKY conserved domain.

[0041] Example 2:

[0042] Analysis of CsWRKY24 gene expression patterns in different tissues of tea plants:

[0043] The test material for this experiment was the nationally approved superior tea variety, Shuchazao, planted in the Agricultural Industrial Park of Anhui Agricultural University, Luyang District, Hefei City, Anhui Province. Eight different tissues and organs of the Shuchazao tea tree were selected for analysis of the expression patterns of the target genes: roots, fruits, flowers, young stems, old stems, young leaves, mature leaves, and buds.

[0044] Total RNA was extracted from each of the collected samples, and cDNA was reverse transcribed. The first-strand cDNA product obtained by reverse transcription was diluted 80-fold and used as a template for real-time quantitative PCR. A 20 μL real-time PCR reaction system was prepared using TOYOBO SYBR Realtime Mix reagent, with the following components: 8.4 μL of 80-fold diluted cDNA template, 0.8 μL each of forward and reverse specific primers at a concentration of 10 pmol / μL, and 10 μL of 2×SYBR Green PCR MasterMix. All reactions were performed in triplicate to ensure the reliability of the experimental data. Amplification and detection were performed using a Bio-Rad CFX-96 real-time quantitative PCR instrument. The specific reaction program was set as follows: pre-denaturation at 95℃ for 3 min; followed by 45 amplification cycles, with single-cycle parameters of denaturation at 95℃ for 10 s, annealing at 60℃ for 15 s, and extension at 72℃ for 30 s; after the amplification program was completed, the temperature was gradually increased from 65℃ to 95℃ at a rate of 0.1℃ / s, and melting curves were plotted to verify the specificity of the amplified products.

[0045] The primer sequences for CsWRKY24 gene amplification in this experiment were: upstream primer 5'-AACAAGGCCTCCAACGACAT-3', downstream primer 5'-TGACCATACCCTAGTGGGAACA-3'; the tea plant ACTIN gene was selected as the internal reference gene, and its internal reference primer sequence was: upstream primer 5'-GCCATATTTGATTGGAATGG-3', downstream primer 5'-GGTGCCACAACCTTGATCTT-3'.

[0046] The relative expression levels of the CsWRKY24 gene in different tea plant tissues were statistically analyzed and calculated using a quantitative real-time PCR machine (CFX Maestro software).

[0047] Figure 2 This is a bar chart illustrating the expression pattern of the CsWRKY24 gene in different tissues of tea plants, as described in this invention. Figure 2As shown, gene expression analysis of different tea plant tissues revealed that the transcriptional level of CsWRKY24 in eight tissues (roots, young stems, old stems, flowers, fruits, buds, young leaves, and mature leaves) was detected using real-time quantitative PCR. The results showed that CsWRKY24 was expressed in all detected tissues, but exhibited significant tissue specificity. The highest expression level was observed in young stems, followed by old stems; the lowest transcriptional abundance of CsWRKY24 was found in flower tissues. Gene expression levels were moderate in terminal buds and mature leaves, while expression levels were generally low in roots, fruits, and young leaves.

[0048] Example 3:

[0049] Validation of CsWRKY24 gene overexpression function in tea plants:

[0050] 1. Overexpression experiment in tea leaves.

[0051] Based on the CsWRKY24 overexpression primers, the overexpression vector pCAMBIA-1305 was constructed. The upstream primer was 5'-GCCCTTGCTCACCATGGATCCATGGCTTCTTCTTCAGAAAT-3', and the downstream primer was 5'-GGACAGCCCAGATCAACTAGTTCATCGTAGGTACGAGTCGA-3'. The recombinant plasmid was then transformed into Agrobacterium GV3101 (pSoup-p19) competent cells and cultured overnight at 28°C in liquid LB containing Kan+Rif. After centrifugation to collect the cells, the cells were resuspended in MMA solution with a final concentration of 10 mM MES and 10 mM MgCl2 to OD600 = 0.6. 100 μM acetylsyl syringone (AS) was added, and the cells were protected from light for 2 h.

[0052] The second and third leaves of one-year-old Shucha early tea trees were infected using the Agrobacterium injection method. After normal culture for 3 days, samples were collected and stored at -80℃. An empty vector (EV) was used as a negative control.

[0053] 2. Analysis of metabolites and related gene expression after overexpression in tea leaves.

[0054] Treatment and control samples were used for total RNA extraction and cDNA first-strand synthesis, respectively. The reverse transcription product (cDNA first strand) was diluted 80-fold as a template, and a 20 μL reaction volume was prepared using SYBR Realtime Mix (TOYOBO, Osaka, Japan), with three replicates per reaction. The relative expression levels of CsWRKY24 and CsTCS1 were then detected using a bio-rad CFX-96 assay (for the caffeine synthase gene CsTCS1, the upstream primer was 5'-GATGGGAGTAGCGGGGTCTT-3', and the downstream primer was 5'-TGGTGCCTGAGTAAGCCAAT-3').

[0055] The results showed that overexpression of CsWRKY24 in tea leaves significantly inhibited the expression level of CsTCS1, a key gene for caffeine synthesis. In addition, metabolite content analysis showed that the caffeine content was significantly reduced.

[0056] The caffeine content of the samples was analyzed using an Agilent high-performance liquid chromatograph (HPLC). Approximately 0.05 g of freshly ground sample powder was weighed, added to 1 mL of 80% methanol extract, mixed thoroughly, and sonicated at room temperature for 1 h. The mixture was then centrifuged at 12000 rpm for 10 min, and the supernatant was filtered through a 0.2 μm filter membrane and transferred to a sample vial for analysis. Chromatographic conditions: C18 column (5 μm, 4.6 × 250 mm), column temperature 39℃, injection volume 5 μL, detection wavelength 280 nm, flow rate 0.8 mL / min, binary gradient elution (phase A: 0.1% glacial acetic acid, phase B: pure methanol): 0.1–5 min 95% A + 5% B; 5–8 min 75% A + 25% B; 8–15 min 70% A + 30% B; 15–25 min 60% A + 40% B; 25–45 min 55% A + 45% B; 45–60 min 45% A + 55% B; 60–65 min 30% A + 70% B; 65–70 min 100% B; 70–75 min 95% A + 5% B. The internal standard method was used for qualitative and quantitative analysis of the target analytes.

[0057] Figure 3 This image shows the results of gene expression and caffeine content detection in tea leaves after transient overexpression of CsWRKY24, as described in an embodiment of the present invention. A represents the CsWRKY24 gene expression level; B represents the CsTCS1 gene expression level; C represents the caffeine content in the leaves; EV represents the empty vector control group; and OE-CsWRKY24 represents the overexpression treatment group. Figure 3As shown, the overexpression experiment on tea leaves can significantly increase the expression level of CsWRKY24 compared to the control. The results of metabolite analysis 3 days after CsWRKY24 gene overexpression show that CsWRKY24 overexpression can significantly inhibit the synthesis and accumulation of caffeine in tea leaves, and the expression level of key structural genes in the caffeine synthesis pathway is also significantly reduced.

[0058] Example 4:

[0059] Functional validation of the CsWRKY24 gene after inhibition in tea plants:

[0060] 1. In vitro oligonucleotide antisense inhibition experiment:

[0061] Oligonucleotide antisense primers were designed and synthesized based on the CsWRKY24 gene sequence. The primer design was completed on the sfold website, and the primer sequence is shown below: 5'-AAGGGTAGTCTTCGGCGAGGAGGT-3'. An in vitro oligonucleotide antisense inhibition buffer was prepared by dissolving the primers in 10mM sucrose solution; a buffer containing only 10mM sucrose and no antisense oligonucleotides was used as a control group (Sense ODN).

[0062] Cut tea buds and leaves of roughly the same size, with vibrant color, healthy appearance, and free from pests and diseases, and insert them into 96-well plates containing buffer solution, ensuring the tail of each bud and leaf is submerged. Place the 96-well plates in a light incubator at 28°C for 16 hours of light followed by 8 hours of darkness. After 3 days of continuous treatment, collect samples from the control group and the antisense oligonucleotide treatment group, and freeze them at -80°C for subsequent gene expression and metabolite detection.

[0063] 2. Analysis of metabolites and related gene expression in in vitro oligonucleotide antisense inhibitory samples:

[0064] The treated and control samples were used for total RNA extraction and cDNA first-strand synthesis, respectively. The reverse transcription product (cDNA first strand) was diluted 80-fold as a template, and a 20 μL reaction system was prepared using SYBR Realtime Mix (TOYOBO, Osaka, Japan), with three replicates for each reaction. The relative expression levels of CsWRKY24 and the key caffeine synthesis gene CsTCS1 were then detected using a Bio-Rad CFX-96 instrument. The caffeine content of the samples was analyzed using an Agilent high-performance liquid chromatograph (HPLC). The HPLC detection method was the same as in Example 3 of this specification.

[0065] Figure 4This figure shows the results of gene expression and caffeine content detection after antisense oligonucleotide inhibition of the endogenous CsWRKY24 gene in an embodiment of the present invention; where A represents the CsWRKY24 gene expression level; B represents the CsTCS1 gene expression level; C represents the leaf caffeine content; SenseODN is the control group, and CsWRKY24-KD is the antisense inhibition treatment group. Figure 4 The results of study A showed that, compared with the Sense ODN control group, the expression of the endogenous CsWRKY24 gene in tea plants was significantly suppressed in the CsWRKY24-KD antisense inhibition treatment group; Figure 4 Results B showed that after the expression of the CsWRKY24 gene was suppressed, the expression level of the key gene CsTCS1 in caffeine synthesis was significantly upregulated; Figure 4 The results of the detection of caffeine content in CsWRKY24-KD showed that the caffeine content in the leaves of the CsWRKY24-KD treatment group was significantly higher than that in the SenseODN control group.

[0066] The above results demonstrate that inhibiting the expression of the endogenous CsWRKY24 gene in tea plants can relieve the transcriptional repression of the CsTCS1 gene by CsWRKY24 and increase the synthesis and accumulation of caffeine in tea leaves.

[0067] Example 5:

[0068] Verification of the molecular mechanism by which CsWRKY24 regulates caffeine synthesis:

[0069] This embodiment verifies the in vitro interaction between CsWRKY24 protein and the CsTCS1 promoter using a yeast one-hybrid assay, and verifies the transcriptional repression activity of CsWRKY24 on the CsTCS1 promoter in plant cells using a dual-luciferase reporter gene assay. Details are as follows:

[0070] 1. Verification of the interaction between the CsWRKY24 and CsTCS1 promoters:

[0071] The CsWRKY24 gene was constructed into the yeast expression vector pGADT7 using homologous recombination (upstream primer: 5'-ATGGCCATGGAGGCCAGTGAATTCATGGCTTCTTCTTCAGAAAT-3', downstream primer: 5'-CTGCAGCTCGAGCTCGATGGATCCTCATCGTAGGTACGAGTCGA-3'); the promoter fragment of the caffeine synthase gene CsTCS1 was constructed into the yeast single-hybrid vector pHIS2.1 (upstream primer: 5'-GACTCACTATAGGGCGAATTCGTGAATCCTGAAAATTCAAACC-3', downstream primer: 5'-GCGTGAGCTCCCCGGGAATTCCACCTTCCCCGTAGTAGCTA-3'), resulting in the bait vector pHIS2.1-CsTCS1pro.

[0072] Take the Y187 strain of *Saccharomyces cerevisiae* stored at -80℃, streak it on a YPDA agar plate, and incubate at 28℃ for 3 days to activate the strain. Pick a single colony and inoculate it into 3 mL of YPDA liquid medium, incubate overnight at 28℃ with shaking at 200 rpm. Centrifuge at 3000 rpm for 5 min, discard the supernatant, and collect the cells. Prepare competent yeast cells according to the Super Yeast Competent Cell Preparation and Transformation Kit (Coolaber, SK2401-200T) instructions. Resuspend the precipitate in 3 mL of Y1 solution, centrifuge at 3000 rpm for 5 min, and discard the supernatant. Resuspend the precipitate in 1 mL of Y2 solution, and aliquot the competent cells into 50 µL containers. Add 350 µL of Y3 solution, 5 µL of 200 ng / µL pGADT7-CsWRKY24, and 5 µL of pHIS2-proCsTCS1 plasmid to competent cells, and repeatedly aspirate and mix well. Use 5 µL of pGADT7 empty AD plasmid as a negative control. Heat shock in a 28℃ water bath for 60 min, mixing every 10 min. Centrifuge at 12000 rpm for 15 s and discard the supernatant. Resuspend the bacterial cells in 350 µL of deionized sterile water and spread them on SD-Leu / Trp plates, incubating at 28℃ for 3 days. Pick a single colony, dissolve it in 500 µL of sterile water, and aspirate 5 µL of the bacterial solution onto SD-Leu / Trp / His medium. Incubate at 28℃ for 5 days and observe the growth of the strain to verify the regulatory relationship between CsWRKY24 and the CsTCS1 promoter.

[0073] 2. Cloning of the CsTCS1 promoter and construction of a dual-luciferase vector:

[0074] Using young leaves of the tea cultivar Shuchazao as material, DNA was extracted using the Tiangen Plant-Specific DNA Extraction Kit, strictly following the kit's instructions. Total DNA concentration was measured using a GeneQuant II spectrophotometer (Fisher Scientific, CA, USA), then adjusted to 50 ng / μL with TE (10 mM Tris, 1 mM EDTA pH 8.0) solution and stored at -20℃ for later use. The DNA was then used as an RT-PCR template, and PCR was performed using standard methods to amplify the CsTCS1 promoter sequence; the upstream primer was (5'-CCGGGCCCCCCCTCGAGGTCGACGTGAATCCTGAAAATTCAAACC-3'), and the downstream primer was (5'-GCCGCTCTAGAACTAGTGGATCCCACCTTCCCCGTAGTAGCTA-3'). A 25 μL PCR system was prepared: 2.5 μL of 10×Ex Taq buffer, 2.0 μL of dNTPs, and MgCl2 solution (Mg... 2+ 1.5 μL of reagents, 1 μL each of forward and reverse primers, 0.2 μL of ExTaq enzyme, 1 μL of template, and 15.8 μL of ddH2O. PCR program: 95℃ pre-denaturation for 5 min; 95℃ for 50 s, 58℃ for 50 s, 72℃ for 2 min, 35 cycles; final extension at 72℃ for 10 min. After purification, the PCR product was ligated into the pMD19-TSimple vector (Takara) to construct the pMD19-T-proCsTCS1 plasmid, transformed into DH5α competent cells, and sequenced for verification.

[0075] 3. Promoter activation / inhibition experiments:

[0076] The CsTCS1 promoter fragment was recombined into the promoter activation vector pGreen0800. The upstream primer for CsTCS1 pro was (5'-CCGGGCCCCCCCTCGAGGTCGACGTGAATCCTGAAAATTCAAACC-3'); the downstream primer for CsTCS1 pro was (5'-GCCGCTCTAGAACTAGTGGATCCCACCTTCCCCGTAGTAGCTA-3'). CsWRKY24 was cloned into the promoter activation vector pCAMBIA-1305 via homologous recombination. The upstream primer used was (5'-GCCCTTGCTCACCATGGATCCATGGCTTCTTCTTCAGAAAT-3'), and the downstream primer was (5'-GGACAGCCCAGATCAACTAGTTCATCGTAGGTACGAGTCGA-3'). The expression was then performed in tobacco to verify promoter activation activity.

[0077] The specific method is as follows:

[0078] (1) Construct the corresponding carrier.

[0079] (2) Pick a single colony of Agrobacterium transformed with recombinant plasmid, inoculate it into 2 mL of LB liquid medium (with the corresponding antibiotic added), and incubate overnight at 28°C and 220 rpm.

[0080] (3) Agrobacterium was cultured until its OD600 was 1.0. After centrifugation at 1700 xg for 5 min to collect the cells, the cells were washed twice with MMA solution (MgCl2 15 mM, MES 0.1%, AS 0.1%). The OD600 of Agrobacterium was adjusted to 1.0 with MMA liquid medium containing 150 μmol / L acetylsuccinone.

[0081] (4) Mix the Agrobacterium tumefaciens bacterial solutions to be tested so that the OD600 of each bacterial solution is 0.6.

[0082] (5) Select fully extended tobacco leaves with a growth period of about 1 month, and inject the mixed bacterial solution from the back of the tobacco leaf using a 1mL syringe (with the needle removed). To ensure the consistency of the experimental results, the bacterial solutions of the control vector and the target vector to be tested need to be injected into different parts of the same leaf to ensure the same growth background.

[0083] (6) Under normal greenhouse growth conditions, samples can be taken for observation after 48 hours.

[0084] (7) Take 3 blades with a diameter of 6-8 mm, put them into a 2 mL EP tube (with 3 small steel balls placed in advance), freeze with liquid nitrogen, and grind them using a crusher (45 Hz, 30 s). After complete crushing, add 100 μL of lysis buffer to the EP tube.

[0085] (8) Incubate on ice for about 5 minutes to fully lyse the leaves.

[0086] (9) Centrifuge at 10,000 rpm for 1 min and collect the supernatant.

[0087] (10) Add 140 μL of 1×PLB lysis buffer, shake to mix, and lyse at room temperature for about 15 min.

[0088] (11) Centrifuge at 4℃ for 10 min and transfer the supernatant to another clean centrifuge tube for later use.

[0089] (12) Microplate reader settings: Set the measurement delay time to 2s and the measurement time to 10s.

[0090] (13) Transfer 40 μL of PLB lysis buffer into the detection tube, and set up 3 replicates for each sample.

[0091] (14) Add 40 μL of LAR II to the test tube, mix well, and test the activity of firefly luciferase. The reading is RLU1.

[0092] (15) Immediately add 40 μL of 1×Stop&Glo®Reagent to the test tube and test the activity of Renali luciferase. The reading is RLU2.

[0093] (16) Calculate the reaction intensity ratio of firefly luciferase (LUC) and Renilla luciferase (REN) Ratio = RLU1 / RLU2.

[0094] Figure 5 The diagram shows the results of the interaction verification between the CsWRKY24 and CsTCS1 promoters in this embodiment of the invention; where A is the result of the yeast one-hybrid experiment; B is a schematic diagram of the construction of the dual-luciferase vector; C is a fluorescence imaging image of tobacco leaves; and D is a bar chart of the relative activity detection of the CsTCS1 promoter.

[0095] like Figure 5 As shown in Figure A, on the selection plate with added histidine (+His), both the experimental group and the negative control group yeasts were able to grow normally; on the selection plate without histidine (-His), only the yeast strain co-transformed with pGADT7-CsWRKY24 and pHIS2.1-CsTCS1pro was able to grow normally, while the empty vector control group could not grow; this result proves that the CsWRKY24 protein can bind to the promoter sequence of the CsTCS1 gene in yeast.

[0096] like Figure 5 Figure B shows a schematic diagram of the construction of the dual-luciferase reporter system vector. EV is the empty vector control; CsWRKY24 is the effector vector, with the 35S promoter driving the expression of the CsWRKY24 transcription factor; CsTCS1Pro::LUC is the reporter vector, with Ren as an internal control, and the CsTCS1 promoter driving the expression of Luc luciferase, used to detect the transcriptional regulatory ability of CsWRKY24 on the CsTCS1 promoter.

[0097] like Figure 5 As shown in C, the fluorescence signal in the leaves of the EV unloaded control group was stronger, while the fluorescence signal in the CsWRKY24 co-expression region was significantly weakened.

[0098] like Figure 5 As shown in D, compared with the EV empty control group, the relative activation activity of the CsTCS1 gene promoter was significantly reduced after co-expression of CsWRKY24.

[0099] The above experimental results indicate that the CsWRKY24 protein can directly bind to the promoter of the caffeine synthase gene CsTCS1 and significantly inhibit the transcriptional activity of the CsTCS1 promoter in plant cells, thus elucidating the mechanism by which CsWRKY24 negatively regulates the biosynthesis of caffeine in tea plants at the molecular level.

[0100] The above is an exemplary description of the invention. Obviously, the specific implementation of the invention is not limited to the above-described manner. Any non-substantial improvement made using the inventive concept and technical solution of the invention, or the direct application of the inventive concept and technical solution to other situations without modification, is within the protection scope of the invention.

Claims

1. A CsWRKY24 gene, characterized in that, The nucleotide sequence of the CsWRKY24 gene is shown in the sequence table SEQ ID NO.

1. 2.The CsWRKY24 gene of claim 1, characterized in that, The amino acid sequence coded by the CsWRKY24 gene is shown in the sequence table SEQ ID NO.

2.

3. A recombinant expression vector, characterized in that, The recombinant expression vector contains the nucleotide sequence of the CsWRKY24 gene shown in the sequence table SEQ ID NO.

1.

4. The recombinant expression vector of claim 3, wherein, The recombinant expression vector is pMD TM 19-T-CsWRKY24, a gene fragment shown in SEQ ID NO. 1 is connected to pMD TM 19-T Simple Vector carrier is obtained.

5. A genetically engineered bacterium, characterized by, The genetically engineered bacteria contain the recombinant expression vector of claim 3; and the genetically engineered bacteria are Escherichia coli DH5a strain or Agrobacterium GV3101 strain.

6. Application of CsWRKY24 gene in regulating synthesis of caffeine in tea leaves, characterized in that, The nucleotide sequence of the CsWRKY24 gene is shown in the sequence table SEQ ID NO. 1; the CsWRKY24 is a negative regulatory factor of caffeine synthesis, which inhibits the expression of the CsTCS1 gene by binding to the promoter of the caffeine synthesis enzyme gene CsTCS1, and then reduces the accumulation of caffeine in tea leaves.

7. The use of the CsWRKY24 gene in regulating the synthesis of caffeine in tea leaves according to claim 6, characterized in that, The application also provides a method for breeding a low-caffeine tea variety.

8. A method of modulating caffeine synthesis in tea plant leaves, the method comprising, The method comprises the following steps: (1) cloning the CsWRKY24 gene according to claim 1; (2) constructing the recombinant expression vector pMD TM 19-T-CsWRKY24; (3) introducing the recombinant expression vector into tea leaves to realize overexpression of the CsWRKY24 gene in the tea leaves and inhibit caffeine synthesis.

9. A method of modulating caffeine synthesis in tea plant leaves, the method comprising, The specific steps are as follows: the expression of the CsWRKY24 gene in tea plants is inhibited by using antisense oligonucleotide technology, the inhibition of the CsWRKY24 gene on the CsTCS1 gene is removed, and the caffeine content in tea leaves is increased.

10. The method for regulating the synthesis of caffeine in tea leaves according to claim 9, wherein, The sequence of the antisense oligonucleotide is as follows: 5'-AAGGGTAGTCTTCGGCGAGGAGGT-3'.